Japan Approves KM Biologics’ Smallpox Vaccine for Monkeypox

August 2, 2022
The Japanese government on August 2 approved KM Biologics’ freeze-dried smallpox vaccine LC16 “KMB” for an additional indication for the prevention of monkeypox. The green light comes days after the label expansion gained the backing of the Pharmaceutical Affairs and...read more